Determining the necessity of phenyl ring π-character in warfarin
- 1 August 2019
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 29 (15) , 1954-1956
Abstract
No abstract availableKeywords
Funding Information
- Department of Agriculture and Water Resources, Australian Government (CT-06)
- National Institutes of Health (HL131690)
- University of Queensland
- National Heart, Lung, and Blood Institute
- Commonwealth Scientific and Industrial Research Organisation (Melbourne)
- Australian Research Council (FT110100851)
- Australian Research Council (DP180103004)
This publication has 40 references indexed in Scilit:
- Evaluation of warfarin resistance using transcription activator‐like effector nucleases‐mediated vitamin K epoxide reductase knockout HEK293 cellsJournal of Thrombosis and Haemostasis, 2013
- Polymorphisms in VKORC1 have more impact than CYP2C9 polymorphisms on early warfarin International Normalized Ratio control and bleeding ratesBritish Journal of Haematology, 2012
- New Phenylglycine‐Derived Primary Amine Organocatalysts for the Preparation of Optically Active WarfarinEuropean Journal of Organic Chemistry, 2009
- The story of the discovery of heparin and warfarinBritish Journal of Haematology, 2008
- Ru-based oxidation catalysisChemical Society Reviews, 2005
- Barton Decarboxylation of Cubane-1,4-dicarboxylic Acid: Optimized Procedures for Cubanecarboxylic Acid and CubaneSynthesis, 1995
- Cubanes: Starting Materials for the Chemistry of the 1990s and the New CenturyAngewandte Chemie International Edition, 1992
- Ruthenium oxo complexes as organic oxidantsChemical Society Reviews, 1992
- Synthesis and chemistry of cubanesChemical Reviews, 1989
- The Discovery of Dicumarol and Its SequelsCirculation, 1959